HIV / AIDS in the News

Dig In! Dining Out For Life 2026 Invites You to Eat Out to Support Local HIV Efforts - poz.com

 

St. Louis clinic 'blindsided' by Missouri cuts to services for HIV patients - STLtoday.com

 

Optimizing Hepatitis B Vaccination in HIV Patients with Suboptimal Immune Response - Drug Topics

 

One in three young women in Africa have never tested for HIV – new study shows where the gaps lie - UNSW Sydney

 

Merck steps up as ‘meaningful competitor’ to Gilead with HIV pill approval - BioSpace

 

FDA approves MSD’s once-daily HIV combo Idvynso - Pharmaceutical Technology

 

US regulator clears Merck’s two-drug HIV switch therapy Idvynso - The Pharma Letter

 

US regulator clears Merck’s two-drug HIV switch therapy Idvynso - The Pharma Letter

 

Drug-Resistant Shigella Surges in Adult Men - Medscape

 

FDA approves new once-daily HIV treatment from MSD - medwatch.com

 

WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV - World Health Organization (WHO)

 

Researchers Dispute US Government's Upbeat Data About PEPFAR’s Impact On HIV - Health Policy Watch

 

Researchers Dispute US Government's Upbeat Data About PEPFAR’s Impact On HIV - Health Policy Watch

 

Two-Drug, Single-Tablet Idvynso Receives FDA Approval for HIV-1 - Medical Professionals Reference

 

Expert quits US HIV role, rebukes Trump's global health approach - MSN

 

Expert quits US HIV role, rebukes Trump's global health approach - Red Lake Nation News

 

[Report] Physicians for Human Rights: Trump administration foreign policy approach to South Africa wastes billions of dollars, imperils global health - European AIDS Treatment Group

 

“Owel” reimagines a queer love story to spotlight HIV/AIDS awareness and stigma - University of the Philippines Los Baños

 

Expert quits US HIV role, rebukes Trump’s global health approach - Internazionale

 

Tucson HIV/AIDS advocate honored for decades of service - KVOA

 

Tucson HIV/AIDS advocate honored for decades of service - KVOA

 

Merck’s New HIV Drug And Mixed Oncology Data Reframe Growth Story - simplywall.st

 

Merck (MRK) Receives FDA Approval for Idvynso, a New HIV Treatme - GuruFocus

 

Wanted: new writers for aidsmap - European AIDS Treatment Group

 

Merck Weighs New HIV Approval Against Mixed Oncology Trial Results - Yahoo Finance

 

Ethical considerations and incentives in biomedical HIV research - Inside UCR

 

The Telegraph: One-in-three Russians should be tested for HIV every year, urges health minister - European AIDS Treatment Group

 

FDA Approves Doravirine/Islatravir as Treatment for HIV - Drug Topics

 

Expert quits US HIV role, rebukes Trump global health approach - The Straits Times

 

U.S. HIV/AIDS Chief Science Officer Resigns, Criticizes Aid Policy - Devdiscourse